Haematologica (Feb 2022)

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

  • Idanna Innocenti,
  • Gianluigi Reda,
  • Andrea Visentin,
  • Marta Coscia,
  • Marina Motta,
  • Roberta Murru,
  • Riccardo Moia,
  • Massimo Gentile,
  • Elsa Pennese,
  • Francesca Maria Quaglia,
  • Francesco Albano,
  • Ramona Cassin,
  • Marina Deodato,
  • Claudia Ielo,
  • Anna Maria Frustaci,
  • Alfonso Piciocchi,
  • Arianna Rughini,
  • Valentina Arena,
  • Daniela Di Sevo,
  • Annamaria Tomasso,
  • Francesco Autore,
  • Giovanni Del Poeta,
  • Lydia Scarfò,
  • Francesca Romana Mauro,
  • Alessandra Tedeschi,
  • Livio Trentin,
  • Maurizio Pompili,
  • Robin Foà,
  • Paolo Ghia,
  • Antonio Cuneo,
  • Luca Laurenti

DOI
https://doi.org/10.3324/haematol.2021.280325
Journal volume & issue
Vol. 107, no. 6

Abstract

Read online

No abstracts available.